| Mollyann Hunt, BS, DPT | |
|
2635 Nw Rolling Green Dr, Corvallis, OR 97330-3519 | |
| (541) 752-0545 | |
| (541) 757-0545 |
| Full Name | Mollyann Hunt |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 8 Years |
| Location | 2635 Nw Rolling Green Dr, Corvallis, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003354630 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 62067 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healing Motion Physical Therapy, Inc. | 8426078361 | 18 |
News Archive
Becton, Dickinson and Company today announced that it completed its acquisition of CareFusion Corporation pursuant to the terms of its previously announced Agreement and Plan of Merger, dated October 5, 2014 (the "Merger Agreement").
Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase (sEH) inhibitor, the drug controls angiogenesis (blood vessel formation), limiting a tumor's ability to grow and spread.
Using tiny solar-panel-like cells surgically placed underneath the retina, scientists at the Stanford University School of Medicine have devised a system that may someday restore sight to people who have lost vision because of certain types of degenerative eye diseases.
Among patients with suspected stage I/II pulmonary sarcoidosis who were undergoing confirmation of the condition via tissue sampling, the use of the procedure known as endosonographic nodal aspiration compared with bronchoscopic biopsy, the current diagnostic standard, resulted in greater diagnostic yield, according to a study in the June 19 issue of JAMA.
At age 17, all Meghan Rothschild and Brittany Lietz wanted was a dark tan. They thought it made them look beautiful. But both had no idea that in just three years they would be battling melanoma, the deadliest form of skin cancer. Now Meghan, 24, of Wilbraham, Mass., and Brittany, 23, of Annapolis, Md., are speaking out about their experiences.
› Verified 2 days ago
| Provider Name | Healing Motion Physical Therapy, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1316919327 PECOS PAC ID: 8426078361 Enrollment ID: O20051206000995 |
News Archive
Becton, Dickinson and Company today announced that it completed its acquisition of CareFusion Corporation pursuant to the terms of its previously announced Agreement and Plan of Merger, dated October 5, 2014 (the "Merger Agreement").
Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase (sEH) inhibitor, the drug controls angiogenesis (blood vessel formation), limiting a tumor's ability to grow and spread.
Using tiny solar-panel-like cells surgically placed underneath the retina, scientists at the Stanford University School of Medicine have devised a system that may someday restore sight to people who have lost vision because of certain types of degenerative eye diseases.
Among patients with suspected stage I/II pulmonary sarcoidosis who were undergoing confirmation of the condition via tissue sampling, the use of the procedure known as endosonographic nodal aspiration compared with bronchoscopic biopsy, the current diagnostic standard, resulted in greater diagnostic yield, according to a study in the June 19 issue of JAMA.
At age 17, all Meghan Rothschild and Brittany Lietz wanted was a dark tan. They thought it made them look beautiful. But both had no idea that in just three years they would be battling melanoma, the deadliest form of skin cancer. Now Meghan, 24, of Wilbraham, Mass., and Brittany, 23, of Annapolis, Md., are speaking out about their experiences.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mollyann Hunt, BS, DPT 2635 Nw Rolling Green Dr, Corvallis, OR 97330-3519 Ph: (541) 752-0545 | Mollyann Hunt, BS, DPT 2635 Nw Rolling Green Dr, Corvallis, OR 97330-3519 Ph: (541) 752-0545 |
News Archive
Becton, Dickinson and Company today announced that it completed its acquisition of CareFusion Corporation pursuant to the terms of its previously announced Agreement and Plan of Merger, dated October 5, 2014 (the "Merger Agreement").
Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase (sEH) inhibitor, the drug controls angiogenesis (blood vessel formation), limiting a tumor's ability to grow and spread.
Using tiny solar-panel-like cells surgically placed underneath the retina, scientists at the Stanford University School of Medicine have devised a system that may someday restore sight to people who have lost vision because of certain types of degenerative eye diseases.
Among patients with suspected stage I/II pulmonary sarcoidosis who were undergoing confirmation of the condition via tissue sampling, the use of the procedure known as endosonographic nodal aspiration compared with bronchoscopic biopsy, the current diagnostic standard, resulted in greater diagnostic yield, according to a study in the June 19 issue of JAMA.
At age 17, all Meghan Rothschild and Brittany Lietz wanted was a dark tan. They thought it made them look beautiful. But both had no idea that in just three years they would be battling melanoma, the deadliest form of skin cancer. Now Meghan, 24, of Wilbraham, Mass., and Brittany, 23, of Annapolis, Md., are speaking out about their experiences.
› Verified 2 days ago
Lori Mueller, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 815 Nw 9th St Ste 180, Corvallis, OR 97330 Phone: 541-768-5157 | |
Mr. Paul Emerson Jaques, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2350 Nw Century Dr, Corvallis, OR 97330 Phone: 541-754-1265 | |
Dr. Travis Michael Obermire, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 845 Sw 30th St, Corvallis, OR 97331 Phone: 541-768-7700 | |
Samaritan Athletic Medicine Center Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 845 Sw 30th Street, Corvallis, OR 97331 Phone: 541-768-7700 Fax: 541-768-9784 | |
Cassie Ross, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1122 Ne 2nd St, Corvallis, OR 97330 Phone: 541-250-4525 Fax: 541-250-4570 | |
Mr. Gary Michael Gray, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2350 Nw Century Dr, Suite 100, Corvallis, OR 97330 Phone: 541-754-1150 |